Ted Rogers Centre for Heart Research Cardiac Genome Clinic, The Hospital for Sick Children, Toronto, ON, Canada.
Division of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada.
Eur J Hum Genet. 2024 Jul;32(7):795-803. doi: 10.1038/s41431-024-01629-4. Epub 2024 May 22.
Pathogenic variants in NOTCH1 are associated with non-syndromic congenital heart disease (CHD) and Adams-Oliver syndrome (AOS). The clinical presentation of individuals with damaging NOTCH1 variants is characterized by variable expressivity and incomplete penetrance; however, data on systematic phenotypic characterization are limited. We report the genotype and phenotype of a cohort of 33 individuals (20 females, 13 males; median age 23.4 years, range 2.5-68.3 years) from 11 families with causative NOTCH1 variants (9 inherited, 2 de novo; 9 novel), ascertained from a proband with CHD. We describe the cardiac and extracardiac anomalies identified in these 33 individuals, only four of whom met criteria for AOS. The most common CHD identified was tetralogy of Fallot, though various left- and right-sided lesions and septal defects were also present. Extracardiac anomalies identified include cutis aplasia (5/33), cutaneous vascular anomalies (7/33), vascular anomalies of the central nervous system (2/10), Poland anomaly (1/33), pulmonary hypertension (2/33), and structural brain anomalies (3/14). Identification of these findings in a cardiac proband cohort supports NOTCH1-associated CHD and NOTCH1-associated AOS lying on a phenotypic continuum. Our findings also support (1) Broad indications for NOTCH1 molecular testing (any familial CHD, simplex tetralogy of Fallot or hypoplastic left heart); (2) Cascade testing in all at-risk relatives; and (3) A thorough physical exam, in addition to cardiac, brain (structural and vascular), abdominal, and ophthalmologic imaging, in all gene-positive individuals. This information is important for guiding the medical management of these individuals, particularly given the high prevalence of NOTCH1 variants in the CHD population.
NOTCH1 中的致病变异与非综合征性先天性心脏病 (CHD) 和 Adams-Oliver 综合征 (AOS) 有关。具有破坏性 NOTCH1 变异的个体的临床表现具有变异性表达和不完全外显率;然而,关于系统表型特征的数据有限。我们报告了一个由 33 名个体(20 名女性,13 名男性;中位数年龄 23.4 岁,范围 2.5-68.3 岁)组成的队列的基因型和表型,这些个体来自一个患有 CHD 的先证者的 11 个家庭,携带致病的 NOTCH1 变异(9 个遗传,2 个新发;9 个新)。我们描述了这些 33 名个体中发现的心脏和心脏外异常,只有 4 名符合 AOS 的标准。确定的最常见的 CHD 是法洛四联症,但也存在各种左侧和右侧病变和间隔缺损。确定的心脏外异常包括皮肤发育不全(5/33)、皮肤血管异常(7/33)、中枢神经系统血管异常(2/10)、波兰异常(1/33)、肺动脉高压(2/33)和结构性脑异常(3/14)。在心脏先证者队列中发现这些发现支持 NOTCH1 相关 CHD 和 NOTCH1 相关 AOS 位于表型连续体上。我们的研究结果还支持 (1) 对 NOTCH1 分子检测的广泛指示(任何家族性 CHD、单纯性法洛四联症或左心发育不全);(2) 对所有高危亲属进行级联检测;(3) 对所有基因阳性个体进行全面的体格检查,除了心脏、大脑(结构和血管)、腹部和眼科成像外。这些信息对于指导这些个体的医疗管理非常重要,特别是考虑到 NOTCH1 变异在 CHD 人群中的高患病率。